Healthcare refers to the field associated with maintaining or restoring patients’ health. These days’ Healthcare Industry falls into a lashing of discrete sub-sectors, and ancillary goods and services. Ranging from therapeutic equipment to medicinal drugs, medical tourism to sickness insurance, the Healthcare Market has been one of the most swiftly expanding sectors within the globe’s economic system.
Global Healthcare spending contributes close to 10% to the whole world’s GDP, though it varies noticeably with geography. Thus, the Western world’s average healthcare costs are far greater in contrast to those in the developing economies. North America alone is in charge of circa a half of the world’s overall spending on healthcare services. With budgets curtailments and growing costs, technology advances are increasingly taking a new meaning in the global Healthcare universe.
The research reports offer comprehensive insights into the market sizing, structure and dynamics of the Healthcare Industry based on various geographies, as well as in-depth market segmentation. The research reports incorporated in this Catalogue closely investigate the competition in the Healthcare Market, besides profiling countless market participants. Moreover, tomorrow's healthcare-related challenges are addressed, as well as projections into the future are provided in the research reports.
Publications found:
67,960
Sort by:
Muscular Dystrophy - Pipeline Review, H2 2020
US$ 2,000.00
... releases. The Muscular Dystrophy (Musculoskeletal Disorders) pipeline guide also reviews of key players involved in therapeutic development for Muscular Dystrophy and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
November 2020
287 pages
Anaplastic Astrocytoma - Pipeline Review, H2 2020
US$ 2,000.00
... releases. The Anaplastic Astrocytoma (Oncology) pipeline guide also reviews of key players involved in therapeutic development for Anaplastic Astrocytoma and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
November 2020
251 pages
Ankylosing Spondylitis (Bekhterev's Disease) - Pipeline Review, H2 2020
US$ 2,000.00
... releases. The Ankylosing Spondylitis (Bekhterev's Disease) (Musculoskeletal Disorders) pipeline guide also reviews of key players involved in therapeutic development for Ankylosing Spondylitis (Bekhterev's Disease) and features dormant and discontinued projects. The guide covers therapeutics under Development ...
November 2020
282 pages
Cytomegalovirus (HHV-5) Infections - Pipeline Review, H2 2020
US$ 2,000.00
... . The Cytomegalovirus (HHV-5) Infections (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Cytomegalovirus (HHV-5) Infections and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
November 2020
200 pages
Endometrial Cancer - Pipeline Review, H2 2020
US$ 2,500.00
... releases. The Endometrial Cancer (Oncology) pipeline guide also reviews of key players involved in therapeutic development for Endometrial Cancer and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
November 2020
1759 pages
Ewing Sarcoma - Pipeline Review, H2 2020
US$ 2,000.00
... releases. The Ewing Sarcoma (Oncology) pipeline guide also reviews of key players involved in therapeutic development for Ewing Sarcoma and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
November 2020
829 pages
Neuroblastoma - Pipeline Review, H2 2020
US$ 2,500.00
... releases. The Neuroblastoma (Oncology) pipeline guide also reviews of key players involved in therapeutic development for Neuroblastoma and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
November 2020
1084 pages
Respiratory Syncytial Virus (RSV) Infections - Pipeline Review, H2 2020
US$ 2,000.00
... . The Respiratory Syncytial Virus (RSV) Infections (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Respiratory Syncytial Virus (RSV) Infections and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
November 2020
319 pages
Spinal Cord Injury - Pipeline Review, H2 2020
US$ 2,000.00
... . The Spinal Cord Injury (Central Nervous System) pipeline guide also reviews of key players involved in therapeutic development for Spinal Cord Injury and features dormant and discontinued projects. The guide covers therapeutics under Development ...
November 2020
264 pages
Vancomycin-Resistant Enterococcus faecium Infections - Pipeline Review, H2 2020
US$ 2,000.00
... The Vancomycin-Resistant Enterococcus faecium Infections (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Vancomycin-Resistant Enterococcus faecium Infections and features dormant and discontinued projects. The guide covers therapeutics under Development ...
November 2020
108 pages
Benign Prostatic Hyperplasia - Pipeline Review, H2 2020
US$ 2,000.00
... . The Benign Prostatic Hyperplasia (Male Health) pipeline guide also reviews of key players involved in therapeutic development for Benign Prostatic Hyperplasia and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
November 2020
129 pages
Escherichia coli Infections - Pipeline Review, H2 2020
US$ 2,000.00
... . The Escherichia coli Infections (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Escherichia coli Infections and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
November 2020
200 pages
Osteonecrosis - Pipeline Review, H2 2020
US$ 2,000.00
... releases. The Osteonecrosis (Musculoskeletal Disorders) pipeline guide also reviews of key players involved in therapeutic development for Osteonecrosis and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
November 2020
35 pages
Burkholderia pseudomallei Infections (Melioidosis) - Pipeline Review, H2 2020
US$ 2,000.00
... . The Burkholderia pseudomallei Infections (Melioidosis) (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Burkholderia pseudomallei Infections (Melioidosis) and features dormant and discontinued projects. The guide covers therapeutics under Development ...
November 2020
48 pages
Cryptosporidiosis - Pipeline Review, H2 2020
US$ 2,000.00
... releases. The Cryptosporidiosis (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Cryptosporidiosis and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
November 2020
37 pages
Gliosarcoma - Pipeline Review, H2 2020
US$ 2,000.00
... releases. The Gliosarcoma (Oncology) pipeline guide also reviews of key players involved in therapeutic development for Gliosarcoma and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
November 2020
423 pages
Glycoprotein 41 (gp41) - Pipeline Review, H2 2020
US$ 3,500.00
... and acquisitions effectively by identifying key players and it’s most promising pipeline therapeutics Devise corrective measures for pipeline projects by understanding Glycoprotein 41 (gp41) development landscape Develop and design in-licensing and ...
November 2020
65 pages
Systemic Mastocytosis - Pipeline Review, H2 2020
US$ 2,000.00
... releases. The Systemic Mastocytosis (Gastrointestinal) pipeline guide also reviews of key players involved in therapeutic development for Systemic Mastocytosis and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
November 2020
203 pages
Hypoparathyroidism - Pipeline Review, H2 2020
US$ 2,000.00
... releases. The Hypoparathyroidism (Hormonal Disorders) pipeline guide also reviews of key players involved in therapeutic development for Hypoparathyroidism and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
November 2020
75 pages
Lung Transplant Rejection - Pipeline Review, H2 2020
US$ 2,000.00
... releases. The Lung Transplant Rejection (Immunology) pipeline guide also reviews of key players involved in therapeutic development for Lung Transplant Rejection and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
November 2020
102 pages
Pemphigus Vulgaris - Pipeline Review, H2 2020
US$ 2,000.00
... releases. The Pemphigus Vulgaris (Immunology) pipeline guide also reviews of key players involved in therapeutic development for Pemphigus Vulgaris and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
November 2020
102 pages
Rubella (German Measles) - Pipeline Review, H2 2020
US$ 2,000.00
... . The Rubella (German Measles) (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Rubella (German Measles) and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
November 2020
45 pages
Chondrosarcoma - Pipeline Review, H2 2020
US$ 2,000.00
... releases. The Chondrosarcoma (Oncology) pipeline guide also reviews of key players involved in therapeutic development for Chondrosarcoma and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
November 2020
591 pages
20s Proteasome - Pipeline Review, H2 2020
US$ 3,500.00
... reviews 20s Proteasome targeted therapeutics under development by companies and universities/research institutes based on information derived from company and industry-specific sources The report covers pipeline products ...
November 2020
78 pages
Anaphylaxis - Pipeline Review, H2 2020
US$ 2,000.00
... releases. The Anaphylaxis (Immunology) pipeline guide also reviews of key players involved in therapeutic development for Anaphylaxis and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
November 2020
65 pages
Anaplastic Oligoastrocytoma - Pipeline Review, H2 2020
US$ 2,000.00
... releases. The Anaplastic Oligoastrocytoma (Oncology) pipeline guide also reviews of key players involved in therapeutic development for Anaplastic Oligoastrocytoma and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
November 2020
93 pages
Aplastic Anemia - Pipeline Review, H2 2020
US$ 2,000.00
... releases. The Aplastic Anemia (Hematological Disorders) pipeline guide also reviews of key players involved in therapeutic development for Aplastic Anemia and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
November 2020
122 pages
Gallbladder Cancer - Pipeline Review, H2 2020
US$ 2,000.00
... releases. The Gallbladder Cancer (Oncology) pipeline guide also reviews of key players involved in therapeutic development for Gallbladder Cancer and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
November 2020
821 pages
Gastritis - Pipeline Review, H2 2020
US$ 2,000.00
... releases. The Gastritis (Gastrointestinal) pipeline guide also reviews of key players involved in therapeutic development for Gastritis and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
November 2020
93 pages
Hypothyroidism - Pipeline Review, H2 2020
US$ 2,000.00
... releases. The Hypothyroidism (Hormonal Disorders) pipeline guide also reviews of key players involved in therapeutic development for Hypothyroidism and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
November 2020
35 pages
Impetigo - Pipeline Review, H2 2020
US$ 2,000.00
... releases. The Impetigo (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Impetigo and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
November 2020
48 pages
Kaposi Sarcoma - Pipeline Review, H2 2020
US$ 2,000.00
... releases. The Kaposi Sarcoma (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Kaposi Sarcoma and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
November 2020
390 pages
Peritonitis - Pipeline Review, H2 2020
US$ 2,000.00
... releases. The Peritonitis (Gastrointestinal) pipeline guide also reviews of key players involved in therapeutic development for Peritonitis and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
November 2020
51 pages
Pigmented Villonodular Synovitis - Pipeline Review, H2 2020
US$ 2,000.00
... . The Pigmented Villonodular Synovitis (Musculoskeletal Disorders) pipeline guide also reviews of key players involved in therapeutic development for Pigmented Villonodular Synovitis and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
November 2020
86 pages
Pontine Glioma - Pipeline Review, H2 2020
US$ 2,000.00
... releases. The Pontine Glioma (Oncology) pipeline guide also reviews of key players involved in therapeutic development for Pontine Glioma and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
November 2020
566 pages
Secondary (Hypogonadotropic) Hypogonadism - Pipeline Review, H2 2020
US$ 2,000.00
... . The Secondary Hypogonadism (Male Health) pipeline guide also reviews of key players involved in therapeutic development for Secondary (Hypogonadotropic) Hypogonadism and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
November 2020
72 pages
Vaginal Cancer - Pipeline Review, H2 2020
US$ 2,000.00
... releases. The Vaginal Cancer (Oncology) pipeline guide also reviews of key players involved in therapeutic development for Vaginal Cancer and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
November 2020
475 pages
Axial Spondyloarthritis - Pipeline Review, H2 2020
US$ 2,000.00
... releases. The Axial Spondyloarthritis (Musculoskeletal Disorders) pipeline guide also reviews of key players involved in therapeutic development for Axial Spondyloarthritis and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
November 2020
292 pages
Dermatomyositis - Pipeline Review, H2 2020
US$ 2,000.00
... releases. The Dermatomyositis (Musculoskeletal Disorders) pipeline guide also reviews of key players involved in therapeutic development for Dermatomyositis and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
November 2020
149 pages
Fanconi Anemia - Pipeline Review, H2 2020
US$ 2,000.00
... releases. The Fanconi Anemia (Hematological Disorders) pipeline guide also reviews of key players involved in therapeutic development for Fanconi Anemia and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
November 2020
88 pages
Hepatitis C Virus Envelope Protein E2 - Pipeline Review, H2 2020
US$ 3,500.00
... Hepatitis C Virus Envelope Protein E2 targeted therapeutics under development by companies and universities/research institutes based on information derived from company and industry-specific sources The report covers pipeline products ...
November 2020
34 pages
Heterozygous familial hypercholesterolemia (heFH) - Pipeline Review, H2 2020
US$ 2,000.00
... The Heterozygous familial hypercholesterolemia (Metabolic Disorders) pipeline guide also reviews of key players involved in therapeutic development for Heterozygous familial hypercholesterolemia (heFH) and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
November 2020
116 pages
Hypereosinophilic Syndrome - Pipeline Review, H2 2020
US$ 2,000.00
... releases. The Hypereosinophilic Syndrome (Hematological Disorders) pipeline guide also reviews of key players involved in therapeutic development for Hypereosinophilic Syndrome and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
November 2020
116 pages
Nephrotic Syndrome - Pipeline Review, H2 2020
US$ 2,000.00
... And Sex Hormones) pipeline guide also reviews of key players involved in therapeutic development for Nephrotic Syndrome and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
November 2020
62 pages
Progressive Multifocal Leukoencephalopathy - Pipeline Review, H2 2020
US$ 2,000.00
... . The Progressive Multifocal Leukoencephalopathy (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Progressive Multifocal Leukoencephalopathy and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
November 2020
45 pages
Spinocerebellar Ataxia (SCA) - Pipeline Review, H2 2020
US$ 2,000.00
... . The Spinocerebellar Ataxia (Genetic Disorders) pipeline guide also reviews of key players involved in therapeutic development for Spinocerebellar Ataxia (SCA) and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
November 2020
114 pages
Tularaemia - Pipeline Review, H2 2020
US$ 2,000.00
... releases. The Tularaemia (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Tularaemia and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
November 2020
46 pages
Global HVAC Test Instruments Market Report 2020
US$ 2,350.00
... maintained a relatively optimistic growth, the past four years, HVAC Test Instruments market size to maintain the average annual growth rate of ... next few years, HVAC Test Instruments market size will be further expanded, we expect that by 2022, The market size of the HVAC Test Instruments will reach 567.29 ...
November 2020
122 pages
